Canada Goose (NYSE:GOOS) Rating Lowered to Market Perform at Raymond James

Raymond James cut shares of Canada Goose (NYSE:GOOS) from an outperform rating to a market perform rating in a report issued on Tuesday morning, Marketbeat reports.

GOOS has been the topic of several other research reports. The Goldman Sachs Group boosted their price target on shares of Canada Goose from $11.00 to $12.50 and gave the stock a neutral rating in a research note on Friday, May 17th. Evercore ISI boosted their target price on Canada Goose from $12.00 to $13.00 and gave the stock an in-line rating in a research report on Friday, May 17th. Wedbush initiated coverage on Canada Goose in a report on Friday, July 19th. They set an outperform rating for the company. Finally, Evercore upped their price objective on Canada Goose from $12.00 to $13.00 and gave the stock an in-line rating in a report on Friday, May 17th. Seven research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of Hold and an average price target of $14.42.

Canada Goose Price Performance

Shares of Canada Goose stock opened at $11.39 on Tuesday. Canada Goose has a one year low of $9.80 and a one year high of $18.63. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.95 and a current ratio of 2.39. The stock has a market cap of $1.10 billion, a P/E ratio of 30.78, a P/E/G ratio of 0.68 and a beta of 1.35. The stock’s fifty day moving average is $13.09 and its 200 day moving average is $12.45.

Canada Goose (NYSE:GOOS) last released its earnings results on Thursday, May 16th. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.07. Canada Goose had a net margin of 4.28% and a return on equity of 25.44%. The company had revenue of $265.56 million for the quarter, compared to analysts’ expectations of $232.36 million. Sell-side analysts anticipate that Canada Goose will post 0.81 earnings per share for the current year.

Institutional Trading of Canada Goose

A number of institutional investors have recently bought and sold shares of GOOS. Patient Capital Management LLC raised its holdings in shares of Canada Goose by 16.0% in the fourth quarter. Patient Capital Management LLC now owns 3,842,824 shares of the company’s stock worth $45,537,000 after buying an additional 529,177 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Canada Goose by 6.0% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,543,561 shares of the company’s stock worth $41,991,000 after buying an additional 201,325 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Canada Goose by 1.3% during the 3rd quarter. Vanguard Group Inc. now owns 1,730,101 shares of the company’s stock worth $25,363,000 after buying an additional 21,967 shares in the last quarter. Pinnacle Associates Ltd. raised its holdings in shares of Canada Goose by 1.2% in the first quarter. Pinnacle Associates Ltd. now owns 609,408 shares of the company’s stock valued at $7,349,000 after acquiring an additional 7,067 shares in the last quarter. Finally, Silvercrest Asset Management Group LLC lifted its stake in Canada Goose by 0.5% in the first quarter. Silvercrest Asset Management Group LLC now owns 605,050 shares of the company’s stock worth $7,297,000 after acquiring an additional 2,752 shares during the period. 83.64% of the stock is currently owned by institutional investors.

About Canada Goose

Canada Goose Holdings Inc, together with its subsidiaries, designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies in Canada, the United States, Asia Pacific, Europe, the Middle East, and Africa. The company operates through three segments: Direct-to-Consumer, Wholesale, and Other.